SEC Tracker
Get the app
CNSY · XBRL financial data

Cerenome financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (CNSY's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022†Dec 31, 2023†Dec 31, 2024†Dec 31, 2025
Revenue———4,9135,8245,213
Research and development2,700—9,6989,69010,5808,379
General and administrative6,4066,85310,2388,5449,93912,132
Total operating expenses9,88712,49219,93618,23420,51920,511
Operating income (loss)(9,584)(12,492)(19,712)(13,321)(14,695)(15,298)
Interest income5019147400273116
Interest expense1,107932711395179548
Income tax expense (benefit)000000
Net income (loss)(8,241)(13,399)(20,275)(13,316)(12,978)(22,386)
Earnings per share, basic‡ USD per share—(462.50)(320.83)(106.00)(48.75)(7.25)
Earnings per share, diluted‡ USD per share—(462.50)(320.83)(106.00)(58.50)(7.25)
Weighted average shares, basic‡ thousands of shares—29631262663,112
Weighted average shares, diluted‡ thousands of shares—29631263083,112
  • ‡ Per-share figures and share counts are adjusted for the 1-for-16.666666666666668 stock split (April 2023); filings made before it reported them unadjusted.
  • ‡ Per-share figures and share counts are adjusted for the 1-for-25 stock split (April 2026); filings made before it reported them unadjusted.
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 4x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 10x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (CNSY's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022†Dec 31, 2023†Dec 31, 2024†Dec 31, 2025
Cash and cash equivalents8,34618,40018,1208,554764,256
Short-term investments————3,5304,356
Accounts receivable0—————
Total current assets9,17519,72421,8179,8345,25915,170
Property and equipment, net1,8201,4771,324906448257
Right-of-use asset6363412482027370
Goodwill372372372372372372
Total assets12,10521,98123,86711,3886,63316,325
Accounts payable7892,6118,3644,7589,4743,276
Current portion of long-term debt6,3351,6081,6083,976——
Total current liabilities8,5395,87011,85210,72715,55112,314
Long-term debt—5,0053,786———
Lease liability, non-current528269141853115
Total liabilities9,07411,14517,42212,73615,58212,329
Accumulated deficit(433,511)(446,910)(467,185)(480,501)(493,479)(515,865)
Total stockholders' equity3,03110,8366,445(1,348)(8,949)3,996
Total liabilities and equity12,10521,98123,86711,3886,63316,325
Common shares outstanding (cover page)‡ thousands of shares5153841716806,862
  • ‡ Per-share figures and share counts are adjusted for the 1-for-16.666666666666668 stock split (April 2023); filings made before it reported them unadjusted.
  • ‡ Per-share figures and share counts are adjusted for the 1-for-25 stock split (April 2026); filings made before it reported them unadjusted.
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 4x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 10x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (CNSY's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022†Dec 31, 2023†Dec 31, 2024†Dec 31, 2025
Net income (loss)(8,241)(13,399)(20,275)(13,316)(12,978)(22,386)
Stock-based compensation2476066065695501,540
Depreciation and amortization366395619628723445
Net cash from operating activities(8,434)(10,280)(12,972)(12,851)(10,554)(20,775)
Purchases of property and equipment———16014667
Net cash from investing activities(493)(82)(759)(160)(4,111)(854)
Proceeds from issuing common stock4,00718,67515,0595,527—22,615
Proceeds from issuing equity————7,265—
Repayments of long-term debt5,3072681,6081,6083,996—
Net cash from financing activities(319)20,41613,4513,4456,18730,311
Net change in cash(9,246)10,054(280)(9,566)(8,478)8,682
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 4x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 10x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Cerenome2,366411(7,132)*7.6M1.2 quarters 10-QJun 30, 2026
QT Imaging Holdings10,9247,435(4,837)*14.6M2.3 quarters 10-QJun 30, 2026
NutriBand3,422438(585)*12.2M— 10-QJul 31, 2026
Femasys1,444332(3,936)*8.4M0.4 quarters 10-QJun 30, 2026
DarioHealth6,634not reported(6,083)*9.8M2.3 quarters 10-QJun 30, 2026
HeartBeam8,722not reported(3,342)*56.3M2.6 quarters 10-QJun 30, 2026
electroCore8,5019,450(3,518)*9.0M2.9 quarters 10-QJun 30, 2026
Nephros4,6976,017681*10.9M— 10-QJun 30, 2026
Modular Medical3,920not reported(5,972)8.2M0.7 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.